Gardado en:
| Autor Principal: | |
|---|---|
| Formato: | Recurso digital |
| Idioma: | |
| Publicado: |
Zenodo
2026
|
| Subjects: | |
| Acceso en liña: | https://doi.org/10.5281/zenodo.18939870 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
Table of Contents:
- Adjuvant radiotherapy for head and neck cancer is typically indicated with pathologic N2 or N3 disease or when extracapsular extension is present. These factors significantly raise recurrence risk, supporting the use of adjuvant therapy.